BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Byun, Ja Min | - |
dc.contributor.author | Koh, Youngil | - |
dc.contributor.author | Shin, Dong-Yeop | - |
dc.contributor.author | Kim, Inho | - |
dc.contributor.author | Yoon, Sung-Soo | - |
dc.contributor.author | Lee, Jeong-Ok | - |
dc.contributor.author | Bang, Soo-Mee | - |
dc.contributor.author | Kim, Ki Hwan | - |
dc.contributor.author | Jung, Sung-Hoon | - |
dc.contributor.author | Lee, Won Sik | - |
dc.contributor.author | Park, Yong | - |
dc.contributor.author | Jang, Jun Ho | - |
dc.contributor.author | Han, Jae Joon | - |
dc.contributor.author | Yhim, Ho-Young | - |
dc.contributor.author | Kim, Dae Sik | - |
dc.contributor.author | Lee, Yoo Jin | - |
dc.contributor.author | Lee, Hyewon | - |
dc.contributor.author | Choi, Yun-Suk | - |
dc.contributor.author | Lee, Seok | - |
dc.date.accessioned | 2021-09-03T06:50:44Z | - |
dc.date.available | 2021-09-03T06:50:44Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-05 | - |
dc.identifier.issn | 0390-6078 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/83642 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | FERRATA STORTI FOUNDATION | - |
dc.subject | FRONT-LINE TREATMENT | - |
dc.subject | PHILADELPHIA-CHROMOSOME | - |
dc.subject | ADULT PATIENTS | - |
dc.subject | HYPER-CVAD | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | IMATINIB | - |
dc.subject | THERAPY | - |
dc.subject | PLUS | - |
dc.subject | DASATINIB | - |
dc.subject | PHASE-2 | - |
dc.title | BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Yong | - |
dc.contributor.affiliatedAuthor | Kim, Dae Sik | - |
dc.identifier.doi | 10.3324/haematol.2016.159988 | - |
dc.identifier.scopusid | 2-s2.0-85018964834 | - |
dc.identifier.wosid | 000402490900007 | - |
dc.identifier.bibliographicCitation | HAEMATOLOGICA, v.102, no.5, pp.E187 - E190 | - |
dc.relation.isPartOf | HAEMATOLOGICA | - |
dc.citation.title | HAEMATOLOGICA | - |
dc.citation.volume | 102 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | E187 | - |
dc.citation.endPage | E190 | - |
dc.type.rims | ART | - |
dc.type.docType | Letter | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.subject.keywordPlus | FRONT-LINE TREATMENT | - |
dc.subject.keywordPlus | PHILADELPHIA-CHROMOSOME | - |
dc.subject.keywordPlus | ADULT PATIENTS | - |
dc.subject.keywordPlus | HYPER-CVAD | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | IMATINIB | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | PLUS | - |
dc.subject.keywordPlus | DASATINIB | - |
dc.subject.keywordPlus | PHASE-2 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.